glp-1 side effect lawsuit in louisiana Ozempic effects can move forward Patients claim blindness, bowel injuries

GLP-1 research tablet provides 25 x 7mg tablets of GLP-1 receptor agonist studied in preclinical models for incretin-pathway signaling, metabolic regulation, and energy-balance pathways

Learn why GLP-1 medications cause headaches, which electrolytes help most, and whether Tylenol is safe to use.

Apitegromab (SRK-015), an investigational new drug developed by Scholar Rock, is a fully human IgG4 monoclonal antibody that specifically binds to human Pro-GDF8 or latent GDF8 without binding to mature GDF8 or other closely related growth factors

Discover how this new weight loss drug works alone and as part of CagriSema